E Mesdjian

638 total citations
35 papers, 462 citations indexed

About

E Mesdjian is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, E Mesdjian has authored 35 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 18 papers in Psychiatry and Mental health and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in E Mesdjian's work include Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Neuroscience and Neuropharmacology Research (10 papers). E Mesdjian is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers) and Neuroscience and Neuropharmacology Research (10 papers). E Mesdjian collaborates with scholars based in France, Switzerland and United States. E Mesdjian's co-authors include Charlotte Dravet, Pierre Genton, G Jadot, M Valli, J Roger, Renzo Guerrini, Grace A. Trentin, Nicolas Giraud, Adriana Magaudda and J.C. Montet and has published in prestigious journals such as Journal of Chromatography A, Life Sciences and Epilepsia.

In The Last Decade

E Mesdjian

34 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Mesdjian France 13 260 202 90 84 68 35 462
Graham J. Schapel Australia 14 349 1.3× 377 1.9× 144 1.6× 54 0.6× 43 0.6× 27 589
Ronald C. Reed United States 17 462 1.8× 569 2.8× 190 2.1× 48 0.6× 49 0.7× 42 789
Elaine A. Wilson United Kingdom 11 385 1.5× 394 2.0× 130 1.4× 158 1.9× 52 0.8× 11 529
C. Gomeni France 9 126 0.5× 204 1.0× 60 0.7× 40 0.5× 68 1.0× 12 467
Svetlana Dimova Belgium 11 187 0.7× 210 1.0× 76 0.8× 51 0.6× 71 1.0× 34 421
Onno L. de Klerk Netherlands 8 139 0.5× 82 0.4× 43 0.5× 180 2.1× 51 0.8× 8 362
Alain Vuong United States 17 522 2.0× 564 2.8× 101 1.1× 49 0.6× 34 0.5× 25 710
Gilles Cloutier United States 7 108 0.4× 118 0.6× 73 0.8× 25 0.3× 34 0.5× 19 380
Shingo Ono Japan 13 90 0.3× 270 1.3× 66 0.7× 53 0.6× 27 0.4× 39 494
Jens‐Otto Andreas Germany 11 103 0.4× 104 0.5× 40 0.4× 37 0.4× 15 0.2× 18 458

Countries citing papers authored by E Mesdjian

Since Specialization
Citations

This map shows the geographic impact of E Mesdjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Mesdjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Mesdjian more than expected).

Fields of papers citing papers by E Mesdjian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Mesdjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Mesdjian. The network helps show where E Mesdjian may publish in the future.

Co-authorship network of co-authors of E Mesdjian

This figure shows the co-authorship network connecting the top 25 collaborators of E Mesdjian. A scholar is included among the top collaborators of E Mesdjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Mesdjian. E Mesdjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesdjian, E, et al.. (1999). Metabolism of carbamazepine by CYP3A6: A model for in vitro drug interactions studies. Life Sciences. 64(10). 827–835. 25 indexed citations
2.
Genton, Pierre, et al.. (1998). Carbamazepine Intoxication with Negative Myoclonus After the Addition of Clobazam. Epilepsia. 39(10). 1115–1118. 16 indexed citations
3.
Sennoune, Souad R., et al.. (1996). STEADY STATE PHARMACOKINETICS OF CARBAMAZEPINE--PHENOBARBITAL INTERACTION IN PATIENTS WITH EPILEPSY. Biopharmaceutics & Drug Disposition. 17(2). 155–164. 1 indexed citations
4.
Mesdjian, E, et al.. (1996). Ursodeoxycholate improves hepatobiliary dysfunction induced by valproate-carbamazepine treatment in the rat. Life Sciences. 59(13). 1069–1079. 6 indexed citations
5.
Queneau, P, P Bertault-Pérès, E Mesdjian, Alain Durand, & J.C. Montet. (1993). DIMINUTION OF AN ACUTE CYCLOSPORIN-INDUCED CHOLESTASIS BY TAUROURSODEOXYCHOLATE IN THE RAT. Transplantation. 56(3). 530–534. 17 indexed citations
6.
Iliadis, Athanassios, et al.. (1993). Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy. Epilepsy Research. 14(3). 257–263. 11 indexed citations
7.
Guieu, Régis, et al.. (1993). Central analgesic effect of valproate in patients with epilepsy. Seizure. 2(2). 147–150. 8 indexed citations
8.
Mesdjian, E, L Ciesielski, & P. Mandel. (1992). GABAA sodium independent receptor sites in a strain of rats presenting generalized non-convulsive seizures. Neuroscience Letters. 136(2). 232–235. 2 indexed citations
9.
Genton, Pierre, et al.. (1992). Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients. Biopharmaceutics & Drug Disposition. 13(6). 411–416. 13 indexed citations
10.
Sennoune, Souad R., et al.. (1992). Interactions Between Clobazam and Standard Antiepileptic Drugs in Patients with Epilepsy. Therapeutic Drug Monitoring. 14(4). 269–274. 45 indexed citations
11.
Guieu, Régis, et al.. (1992). Nociceptive threshold in patients with epilepsy. Epilepsy Research. 12(1). 57–61. 26 indexed citations
12.
Jadot, G, et al.. (1990). [Serum beta-glucuronidase activity in patients with epilepsy].. PubMed. 45(2). 151–5. 1 indexed citations
13.
Tamalet, Catherine, et al.. (1986). Antinociceptive action of picrotoxin in the mouse. General Pharmacology The Vascular System. 17(4). 489–491. 4 indexed citations
14.
Hariton, C., et al.. (1985). Valproate increases diazepam impregnation selectively in CNS of the rat after subchronic administration. Life Sciences. 37(14). 1343–1349. 2 indexed citations
15.
Mesdjian, E, F.V. DeFeudis, M Valli, G Jadot, & P. Mandel. (1983). Antinociceptive action of sodium valproate in the mouse. General Pharmacology The Vascular System. 14(6). 697–699. 22 indexed citations
16.
Mesdjian, E, et al.. (1977). [Acute toxicity of 5 intravenous anesthetics in rats depending on age and sex].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(3). 375–80. 2 indexed citations
17.
Bruguerolle, Bernard, et al.. (1975). [Variations in the activity of various curarizing substances as a function of the time of administration].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(5). 349–53. 2 indexed citations
18.
Jadot, G, et al.. (1974). [Demonstration of a nycthemeral rhythm in the phenomenon of curarization in the rat].. PubMed. 168(8-9). 1005–7. 2 indexed citations
19.
Mesdjian, E. (1971). Dosage des cerebrosides et sulfatides cerebraux par chromatographie en couche mince (technique sans élution préalable). Journal of Chromatography A. 57(3). 448–449. 2 indexed citations
20.
Soulayrol, R, et al.. (1965). The Tryptophan Loading Test in Epileptic Childeren. Epilepsia. 6(4). 310–324. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graham J. Schapel Breakdown of academic impact, for papers by Ronald C. Reed Breakdown of academic impact, for papers by Elaine A. Wilson Breakdown of academic impact, for papers by C. Gomeni Breakdown of academic impact, for papers by Svetlana Dimova Breakdown of academic impact, for papers by Onno L. de Klerk Breakdown of academic impact, for papers by Alain Vuong Breakdown of academic impact, for papers by Gilles Cloutier Breakdown of academic impact, for papers by Shingo Ono Breakdown of academic impact, for papers by Jens‐Otto Andreas
Rankless by CCL
2026